ARCHIVES

Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

The Walgreens Connection: ACS Calls On Drug Stores To Stop Tobacco Sales

April 18, 2014

Hopkins Investigator Dies In Fall From Denver Hotel Window

May 27, 1977

Francis Collins Nominated For NIH Director Two Days After Final Stem Cell Guidelines Released.

July 10, 2009

Professional Society Growth Obvious At Spring Meetings; AACR Looking To Broaden Its Base

June 5, 1987

Cancer Genetics Network approved By NCI Advisors, To Start With 8 Centers

November 29, 1996

Statistical Models Determine Stem-Cell Transplant Effectiveness

July 26, 2013